Gate 322 Lofibra 67 mg (Lofibra 67 mg)

Generic Name: fenofibrate

Pill with imprint Gate 322 Lofibra 67 mg is Pink, Capsule-shape and has been identified as Lofibra 67 mg. It is supplied by Gate Pharmaceuticals.

Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 67 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Gate 322 Lofibra 67 mg

Lofibra

Generic Name

fenofibrate

Imprint

Gate 322 Lofibra 67 mg

Strength

67 mg

Color

Pink

Size

14.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Fibric acid derivatives

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Gate Pharmaceuticals

National Drug Code (NDC)

57844-0322

Inactive Ingredients

croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone k25, corn starch, sodium lauryl sulfate, magnesium silicate, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, titanium dioxide

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer